Multiple Myeloma: Updates on Diagnosis and Management

Conclusions

Despite significant advances in the management of MM, the disease remains incurable. Virtually all patients will develop relapsed disease, although strides in the field have provided opportunities for longer term remissions. There are a multitude of strategies that are under investigation, and further studies are needed to establish their role in the treatment of patients with MM.

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Click here to read the digital edition.